Generic Name and Formulations:
Ketorolac tromethamine 0.45%; oph soln; preservative-free.
Indications for ACUVAIL:
Ocular pain and inflammation after cataract surgery.
1 drop in the affected eye twice daily beginning 1 day prior to surgery, continue on day of surgery and through first 2 weeks post-op. Concomitant other topical ophthalmics (eg, alpha-agonists, beta-blockers, carbonic anhydrase inhibitors, cycloplegics, mydriatics): administer at least 5 minutes apart.
Do not administer while wearing contacts. Aspirin/NSAID sensitivity. Asthma. Bleeding tendencies. Complicated or repeated ocular surgeries. Corneal defects/denervation. Ocular surface diseases. Diabetes. Rheumatoid arthritis. May delay wound healing. Monitor cornea; discontinue if corneal epithelial breakdown occurs. Pregnancy (Cat.C): avoid in late pregnancy. Nursing mothers.
Concomitant topical steroids may increase potential for healing problems.
Increased intraocular pressure, conjunctival hyperemia and/or hemorrhage, corneal edema, ocular pain, headache, tearing, blurred vision; keratitis, increased ocular bleeding (including hyphemas).
Single-use vials (0.4mL)—30
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Differences in Efficacy and Tolerability of ADHD Medications Across Age Groups
- Associations Between Hypovitaminosis D and Poorer Outcomes in Schizophrenia
- Oxycontin's Maker Now Selling Drug to Curb Opioid Addiction
- Comorbid Narcolepsy and Schizophrenia in Adolescents
- FDA Approves New Treatment for Opioid Dependence
- Gestational Diabetes Associated With Increased Risk for Postpartum Depression
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Smartphone-Based Psychoeducational Programs May Be Effective for Bipolar Disorder Management
- Prazosin May Be Effective as Treatment for Alcohol Use Disorder
- Risk Factors for Recurrent Suicide Attempts in Substance Use Disorder Outpatients